Twenty years ago, revolutionary new drugs transformed HIV/AIDS, bringing people back from the brink of death. But what happens when you plan to die only to recover? Three people, whose stories span the global epidemic, told BuzzFeed News what it means to have a second ...

During HIV infection, the virus mutates too rapidly for the immune system to combat, but some people produce antibodies that can recognize the virus even two years after infection. With an eye towards developing a vaccine, in four related papers from multiple groups publishing September ...

Analysis of national policies also notes that implementation lag also leads to missed prevention and life-saving opportunities When the World Health Organization issued an early update to its HIV treatment guidelines in September 2015, the new recommendations drew on years of mounting evidence that immediate antiretroviral ...

EMA, FDA and PMDA discuss regulatory approaches for the evaluation of new antibacterial agents Alignment of data requirements by regulators worldwide can contribute to stimulate the development of new antibiotics to fight antimicrobial resistance and protect global public health. However, regulatory activities are only one element ...

Widening access to naloxone, a drug that prevents death from overdose, could save lives For the benefit of anyone who has not heard a “death rattle” before, Jason Wallace puts on a short video clip. One second a cheerful Bulgarian heroin addict is shooting up. The ...

Researchers at the Walter Reed Army Institute of Research (WRAIR) and collaborators recently published results of a phase II study which demonstrated that by changing the dosing regimen, the efficacy of malaria vaccine candidate, RTS,S/AS01, was improved to approximately 87%, compared with 63% using the ...

The worldwide burden of hepatitis C virus (HCV) infection is a major public health concern. New direct antiviral agents (DAAs) have revolutionised the management of HCV infection, with eradication rates higher than 90%. However, their high cost has precluded their widespread use, leading to restrictive ...

A group of researchers has developed a recombinant multiepitope protein (rMEHCV) which can be used in the diagnosis of hepatitis C virus (HCV). The researchers, led by Alexsandro Galdino of the Federal University of Sao Joao in Brazil, detailed their work in a paper published ...

Achillion announces 100% SVR reported in Janssen’s Phase 2a trial evaluating triple combination of odalasvir, AL-335, and simeprevir for genotype 1 treatment-naive HCV Janssen advancing triple combination into Phase 2b clinical trial NEW HAVEN, Conn., Sept. 09, 2016 — Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that new ...

When presented with a range of possible HIV prevention technologies – a daily pill, pills before and after sex, injections, or a rectal gel – gay men in London have a range of views about which methods they would prefer, but the biggest determining factor ...

PrEP is broadly acceptable to London gay men who are at risk of acquiring HIV, with many men seeing its potential to protect them from infection and to reduce anxiety during sex. Nonetheless the lack of honest discussion about sex and risk with friends, peers ...

A research project on human rights abuses experienced by sex workers was conducted by “Amelia” NGO and released on the 5 of November, 2015. The project was financially supported by SWAN and the Robert Carr Foundation. Amelia NGO was founded in 2012 and focuses on: 1. Helping ...

People living with HIV are at increased risk for some cancers. This risk arises from several factors, including co-infection with viruses that have the potential to cause cancer, elevated rates of smoking and alcohol use, and ongoing exposure to proteins produced by HIV. Taking anti-HIV ...

Researchers at Boston Children’s Hospital have developed a technology to quickly generate mouse models for testing and tweaking potential HIV vaccines. Such models could speed up the quest for the AIDS field’s “holy grail”– a vaccine that elicits broadly neutralizing antibodies able to fight any ...

Treatment in prisons a public health priority, says new research 8 September 2016, Oslo: Prisons provide one of the most significant opportunities to drive down the prevalence of hepatitis C, and help reach global WHO elimination goals, says new research presented at the 5th International Symposium ...

Fatigue — a common symptom among people living with hepatitis C virus (HCV) infection — is associated with liver inflammation and fibrosis, but antiviral therapy that leads to a cure significantly reduces the likelihood of fatigue, according to a Danish study presented at the 5th ...

The 5th International Symposium on Hepatitis Care in Substance Users (INHSU 2016) got underway Wednesday with an overview of the epidemiology of hepatitis C virus (HCV) among people who inject drugs and a look at public health and harm reduction approaches to preventing, treating, and ...

A significant proportion of people living with HIV would be willing to take part in a study towards a cure for HIV, according to research presented at the recent 21st International AIDS Conference (AIDS 2016) in Durban. However, some potential participants may not fully understand ...